Epigenetic aberrations and cancer. [Mol Cancer. 2006] - PubMed

loading

Review Chromatin proteomics and epigenetic regulatory circuits. [Expert Rev Proteomics. 2008]
Review Chromatin proteomics and epigenetic regulatory circuits.
Bönisch C, Nieratschker SM, Orfanos NK, Hake SB. Expert Rev Proteomics. 2008 Feb; 5(1):105-19.
Review Epigenetics in cancer: targeting chromatin modifications. [Mol Cancer Ther. 2009]
Review Epigenetics in cancer: targeting chromatin modifications.
Ellis L, Atadja PW, Johnstone RW. Mol Cancer Ther. 2009 Jun; 8(6):1409-20. Epub 2009 Jun 9.
Review Chemical regulation of epigenetic modifications: opportunities for new cancer therapy. [Med Res Rev. 2008]
Review Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.
Zheng YG, Wu J, Chen Z, Goodman M. Med Res Rev. 2008 Sep; 28(5):645-87.
Review Mechanisms of epigenetic inheritance. [Curr Opin Cell Biol. 2007]
Review Mechanisms of epigenetic inheritance.
Martin C, Zhang Y. Curr Opin Cell Biol. 2007 Jun; 19(3):266-72. Epub 2007 Apr 26.
Review Signals and combinatorial functions of histone modifications. [Annu Rev Biochem. 2011]
Review Signals and combinatorial functions of histone modifications.
Suganuma T, Workman JL. Annu Rev Biochem. 2011 Jun 7; 80:473-99.

Epigenomics of ovarian cancer and its chemoprevention. [Front Genet. 2011]
Epigenomics of ovarian cancer and its chemoprevention.
Chen H, Hardy TM, Tollefsbol TO. Front Genet. 2011; 2:67. Epub 2011 Oct 4.
Structural and functional profiling of the human histone methyltransferase SMYD3. [PLoS One. 2011]
Structural and functional profiling of the human histone methyltransferase SMYD3.
Foreman KW, Brown M, Park F, Emtage S, Harriss J, Das C, Zhu L, Crew A, Arnold L, Shaaban S, et al. PLoS One. 2011; 6(7):e22290. Epub 2011 Jul 14.
Epigenetic targets of bioactive dietary components for cancer prevention and therapy. [Clin Epigenetics. 2010]
Epigenetic targets of bioactive dietary components for cancer prevention and therapy.
Meeran SM, Ahmed A, Tollefsbol TO. Clin Epigenetics. 2010 Dec 1; 1(3-4):101-116.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Epigenetic aberrations and cancer.
Epigenetic aberrations and cancer.
Mol Cancer. 2006 Nov 8 ;5:60.

PubMed
The specificity of human anti-cytochrome c autoantibodies that arise in autoimmu...
The specificity of human anti-cytochrome c autoantibodies that arise in autoimmune disease.
J Immunol. 1990 Mar 1 ;144(5):1835-40.

PubMed
Can the state of cancer chemotherapy resistance be reverted by epigenetic therap...
Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
Mol Cancer. 2006 Jul 10 ;5:27.

PubMed
Aspirin use and reduced risk of fatal colon cancer.
Aspirin use and reduced risk of fatal colon cancer.
N Engl J Med. 1991 Dec 5 ;325(23):1593-6.

PubMed
The cancer stem cell: evidence for its origin as an injured autoreactive T cell.
The cancer stem cell: evidence for its origin as an injured autoreactive T cell.
Mol Cancer. 2006 Feb 14 ;5:6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed